News and Announcements
Boosting Success and Efficiency in Capital Raising: Essential Tips for Founders
- Published April 19, 2023 11:00PM UTC
- Publisher Jade Miguel
- Categories Capital Raising Tips
Imagine this scenario: You hire a new business development team member, provide them with nothing but a company brochure, and expect them to generate sales without any training, tools, or resources. The likelihood of success is minimal. Unfortunately, this is the position many founders find themselves in during the capital raising process, armed with just a pitch deck and high expectations.
To avoid wasting time, facing rejection, and losing momentum, consider these tips to increase your success potential and streamline the capital raising process:
- Develop a proven and defined process: Establish a clear strategy for your capital-raising efforts to guide you through each stage and maximise efficiency.
- Use communication templates: Keep your communications simple, concise, and direct. Avoid overwhelming potential investors with lengthy emails or too many attachments, as this can deter them from engaging with your proposal.
- Implement software and analytics: Leverage technology to improve efficiency and gain insights into investor behaviour. Relying on email alone is insufficient in today’s data-driven world.
- Prepare conversation scripts: Structure your investor conversations to present yourself professionally, gather valuable intelligence on potential investors, and ensure you’re always prepared.
- Evaluate your performance: If you’re not securing investments after speaking with numerous investors, identify the issues with your approach or business. Aim for a target investment rate of 1 in 5 investors who access your deal room – a challenging but achievable goal.
By following these five steps, you’ll simplify your capital-raising journey and build a strong foundation of confidence based on process rather than wishful thinking. Optimising your approach to capital raising can make all the difference in the competitive startup landscape.
Capital Raising Tips
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Backed By Leading Investment Groups and Family Offices
